2. Academic Validation
  3. Potential of muvalaplin as a lipoprotein(a) inhibitor

Potential of muvalaplin as a lipoprotein(a) inhibitor

  • Expert Opin Investig Drugs. 2024 Jan;33(1):5-7. doi: 10.1080/13543784.2024.2302592.
Amanda J Hooper 1 2,  P Mihika S Fernando 1,  John R Burnett 1 2
Affiliations

Affiliations

  • 1 Department of Clinical Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital & Fiona Stanley Hospital Network, Perth, Western Australia, Australia.
  • 2 School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
PMID: 38186354 DOI: 10.1080/13543784.2024.2302592
Keywords

ApoB; LDL; LDL-cholesterol; Lp(a); Lp(a) inhibitor; muvalaplin.

Figures
Products